Search

Your search keyword '"Gelpi, E"' showing total 62 results

Search Constraints

Start Over You searched for: Author "Gelpi, E" Remove constraint Author: "Gelpi, E" Database OAIster Remove constraint Database: OAIster
62 results on '"Gelpi, E"'

Search Results

2. Genome wide association study of clinical duration and age at onset of sporadic CJD

3. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8)

4. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8)

5. Genotype-phenotype correlations in valosin-containing protein disease: a retrospective muticentre study

6. Concordance of cerebrospinal fluid real-time quaking-induced conversion across the European Creutzfeldt-Jakob Disease Surveillance Network

7. Concordance of cerebrospinal fluid real-time quaking-induced conversion across the European Creutzfeldt-Jakob Disease Surveillance Network

8. Common Variants Near ZIC1 and ZIC4 in Autopsy-Confirmed Multiple System Atrophy.

9. Tau deposition patterns are associated with functional connectivity in primary tauopathies

10. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

11. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

12. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

13. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

15. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

16. SLITRK2, an X-linked modifier of the age at onset in C9orf72 frontotemporal lobar degeneration

17. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

18. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

19. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

20. Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance

21. Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance

22. Distribution patterns of tau pathology in progressive supranuclear palsy

23. Distribution patterns of tau pathology in progressive supranuclear palsy

24. Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance

25. How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy

26. Does ALS-FUS without FUS mutation represent ALS-FET? Report of three cases

27. An Integrative Study of Protein-RNA Condensates Identifies Scaffolding RNAs and Reveals Players in Fragile X-Associated Tremor/Ataxia Syndrome

28. An Integrative Study of Protein-RNA Condensates Identifies Scaffolding RNAs and Reveals Players in Fragile X-Associated Tremor/Ataxia Syndrome

29. MRI and clinical syndrome in dura materrelated Creutzfeldt-Jakob disease

30. Which ante mortem clinical features predict progressive supranuclear palsy pathology?

31. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

32. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies

33. TBK1 loss-of function and dominant-negative mutations in an extended European cohort of FTD and ALS patients

34. Revised clinical diagnostic criteria for progressive supranuclear palsy (PSP)

35. TBK1 loss-of function and dominant-negative mutations in an extended European cohort of FTD and ALS patients

36. Revised clinical diagnostic criteria for progressive supranuclear palsy (PSP)

37. Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium

38. Erratum to: Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium[Journal of Neural Transmission, (2015), DOI 10.1007/s00702-014-1304-1]

39. The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases

40. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions

41. The need to unify neuropathological assessments of vascular alterations in the ageing brain. Multicentre survey by the BrainNet Europe consortium.

42. The need to unify neuropathological assessments of vascular alterations in the ageing brain : Multicentre survey by the BrainNet Europe consortium

43. This title is unavailable for guests, please login to see more information.

44. This title is unavailable for guests, please login to see more information.

45. This title is unavailable for guests, please login to see more information.

46. Staging of neurofibrillary pathology in Alzheimer's disease: A study of the BrainNet Europe consortium

47. This title is unavailable for guests, please login to see more information.

48. Assessment of a-synuclein pathology: A study of the BrainNet Europe consortium

49. Management of a twenty-first century brain bank: Experience in the BrainNet Europe consortium

50. Management of a twenty-first century brain bank: experience in the BrainNet Europe consortium.

Catalog

Books, media, physical & digital resources